12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Deals

Intellect Neurosciences, Kancera deal

Intellect partnered with Kancera's iNovacia AB subsidiary to evaluate compounds needed to optimize Intellect's Conjumab-A. iNovacia provides high...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >